CM opens AP's 1st Digital Nerve Centre
This initiative, a collaborative effort with Tata Trusts and the Bill & Melinda Gates Foundation, aims at integrating all health services under a single digital platform, beginning in Kuppam and slated for statewide expansion.
The DiNC is designed to seamlessly connect hospitals, primary health centres (PHCs), and village clinics, ensuring that a patient's complete medical history is accessible digitally from anywhere, at any time. This integration is expected to facilitate quicker diagnoses, enhance coordination among medical professionals, and streamline follow-up care. From lab results to prescriptions, all vital health information will be digitized, empowering doctors to make more informed and efficient decisions.
"This is not just a model for Andhra Pradesh, but for the world," stated the Chief Minister after the inauguration. He emphasised that the project transcends mere digitalisation, focusing instead on leveraging technology to profoundly improve people's lives.
Highlighting the state's annual healthcare expenditure of approximately Rs 19,000 crore, the CM underscored the potential of artificial intelligence and advanced data systems to reduce costs while simultaneously delivering superior healthcare services.
Currently, the newly launched centre links 13 PHCs and 92 village health centres within the Kuppam region. This connectivity enables real-time health tracking and ensures rapid response during medical emergencies. During the launch, Chief Minister Naidu and Health Minister Satya Kumar Yadav also engaged with local health workers to assess the system's practical implementation and effectiveness on the ground.
Looking ahead, the government plans to roll out the DiNC system across the remaining part of the Chittoor district in its next phase, followed by a full-scale implementation throughout Andhra Pradesh. The strategy also includes deploying mobile medical units for regular blood tests and more rigorous monitoring of maternal health, with a strong emphasis on preventive care.
A significant strength of the DiNC system lies in its inclusivity, bringing frontline healthcare workers, including Auxiliary Nurse Midwives (ANMs) and Anganwadi staff, into the digital loop. This ensures that even remote and rural communities benefit from enhanced health services.
Special Chief Secretary MT Krishna Babu, Commissioner of Health and Family Welfare Veerapandian, Collector Sumit Kumar, DM&HO Dr DT Sudha Rani, and other senior officials also attended the programme.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
33 minutes ago
- Time of India
Insurance battle ends: 5 years after husband's death; Hyderabad woman wins Rs 50 lakh claim
HYDERABAD: What began as a family's financial safeguard turned into a bitter legal battle after an insurer refused to honour a life insurance claim. Now, nearly five years after her husband's death, a Hyderabad woman has won. The Telangana State Consumer Disputes Redressal Commission has ordered an insurance company to pay her Rs 50 lakh sum assured, plus compensation and interest, for wrongfully denying claim. The story unfolded when a complaint was filed by V Thara, who was left to fend for herself and her three kids following demise of her husband, Vallepu Venugopal, in Aug 2019. Venugopal took an insurance policy in Nov 2018, with a sum assured of Rs 50 lakh. Thara was named as the nominee. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad Following her husband's death due to sudden cardiac arrest, Thara submitted a death claim to insurance company. However, the claim was repudiated on Nov 26, 2019. The insurer argued that Venugopal failed to disclose a pre-existing illness, Chronic Kidney Disease (CKD), and was undergoing dialysis. When the commission began the trial, it found several flaws in the insurer's arguments. Firstly, there was no evidence to show that Venugopal was diagnosed with or treated for chronic kidney disease before the date of policy issuance. The insurer did not conduct any pre-policy medical examination, which it had right and opportunity to do. Medical records produced during the hearing showed that Venugopal died due to sudden cardiac arrest. There was no documentation showing a diagnosis of CKD or ongoing dialysis treatment at the time policy was taken. The commission stated that the insurance company's refusal to settle the claim lacked merit and amounted to a deficiency in service and unfair trade practice. "The insurer should pay Rs 50 lakh with 9% interest per annum from Nov 26, 2019. Additionally, Rs 2 lakh was awarded as compensation for mental agony, and Rs 25,000 was granted as litigation costs," the court order read.
Time of India
33 minutes ago
- Time of India
25-year-old plea: Telangana HC orders land dispute disposal; sets 3-month deadline
HYDERABAD: What began as a family's financial safeguard turned into a bitter legal battle after an insurer refused to honour a life insurance claim. Now, nearly five years after her husband's death, a Hyderabad woman has won. The Telangana State Consumer Disputes Redressal Commission has ordered an insurance company to pay her Rs 50 lakh sum assured, plus compensation and interest, for wrongfully denying claim. The story unfolded when a complaint was filed by V Thara, who was left to fend for herself and her three kids following demise of her husband, Vallepu Venugopal, in Aug 2019. Venugopal took an insurance policy in Nov 2018, with a sum assured of Rs 50 lakh. Thara was named as the nominee. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad Following her husband's death due to sudden cardiac arrest, Thara submitted a death claim to insurance company. However, the claim was repudiated on Nov 26, 2019. The insurer argued that Venugopal failed to disclose a pre-existing illness, Chronic Kidney Disease (CKD), and was undergoing dialysis. When the commission began the trial, it found several flaws in the insurer's arguments. Firstly, there was no evidence to show that Venugopal was diagnosed with or treated for chronic kidney disease before the date of policy issuance. The insurer did not conduct any pre-policy medical examination, which it had right and opportunity to do. Medical records produced during the hearing showed that Venugopal died due to sudden cardiac arrest. There was no documentation showing a diagnosis of CKD or ongoing dialysis treatment at the time policy was taken. The commission stated that the insurance company's refusal to settle the claim lacked merit and amounted to a deficiency in service and unfair trade practice. 'The insurer should pay Rs 50 lakh with 9% interest per annum from Nov 26, 2019. Additionally, Rs 2 lakh was awarded as compensation for mental agony, and Rs 25,000 was granted as litigation costs,' the court order read.
India.com
3 hours ago
- India.com
This is world's most expensive tear; one drop can neutralize 26 snake venoms, it is worth Rs..., it is of...
This is world's most expensive tear; one drop can neutralize 26 snake venoms, it is worth Rs..., it is of... Tears may seem like merely small drops of water but are quite meaningful and important. For centuries, people have talked about tears. People have used phrases like 'crocodile tears' to show that some tears are fake or false. But tears are not always about sadness or pretending. Tears can show feelings, tell stories, and can even have amazing health impacts. Do you know which is the world's most expensive tear? One drop of tear can… What makes camel's tear so powerful against snake venom? In Rajasthan's dry desert land, camels have always been known as the 'ship of the desert' because they help farmers commute long miles through tough lands. Now, these wonderful animals are revealing something even more astounding. Scientists at the National Research Centre on Camel (NRCC) in Bikaner have discovered that the antibodies derived from the camel tears and its immune system could be used to combat snake venom. This is an exciting finding that may eventually lead to improved treatments for victims of snakebites and also yield improved quality of life for farmers who raise camels. Who conducted the study revealing the medicinal power of camel tears? As per a Moneycontrol report, researchers from the NRCC staged a series of experiments in which they immunized camels (Camelus dromedarius) with venom from the saw-scaled viper (Echis carinatus sochureki), which is an extremely venomous snake species. Their findings indicated that antibodies from the camels' blood serum and tears provided effective neutralization of the effects of the venom; most importantly, the venom's effects related to hemorrhage and coagulopathy were greatly abated. Camel-based antibodies also had fewer allergy issues, and effects were more potent than those derived from traditional antivenoms made from horse immunoglobulin (IgG), which are expensive for production and complex to collect. Why is this tear considered the most expensive in the world? India is experiencing a serious snakebite crisis, with nearly 58,000 deaths per year and another 140,000 people with disabilities—the highest-burden worldwide. The NRCC's camel-derived antibodies could lead to lower-cost, safer, and easier-to-produce treatments. This is ultimately great for patients in rural areas, where snakebites are common and timely medical care is more difficult to obtain. This work shows economic transformation for camel-rearing groups in areas such as Bikaner, Jaisalmer, and Jodhpur. The NRCC has worked to convince local farmers to give them access to their camels for quick and safe collection of tears and blood samples; in exchange, farmers are compensated lavishly. According to the report, Pharmaceutical companies such as the Serum Institute of India and other private drug companies are building business models around the camel-derived antibodies, with estimates that farmers can cash additional income of Rs 5,000 to 10,000 per camel each month; this can give the farmers a new, sustainable, and scientifically lucrative source of cash.
